-
Product Insights
Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021" provides an overview of Central Retinal Vein Occlusion Clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
Retinitis Pigmentosa (Retinitis) - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) - Global Clinical Trials Review, H2, 2021" provides an overview of Retinitis Pigmentosa (Retinitis) Clinical trials scenario. This report provides top line data relating to the clinical trials on Retinitis Pigmentosa (Retinitis) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor...
-
Sector Analysis
Uveitis - Epidemiology Forecast to 2029
Uveitis is a condition characterized by the inflammation of the uveal tract (iris, ciliary body, and choroid), but can also cause the inflammation of nearby tissues, such as the retina, the optic nerve, and the vitreous humor. Uveitis can affect one or both eyes. It primarily affects people ages 20-60 years, but can present at any age (National Eye Institute, 2019; Medscape, 2020). Uveitis is an important cause of blindness and visual loss in many communities (Wakefield and Chang, 2005)....
-
Product Insights
Graves' Ophthalmopathy Disease - Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Graves' Ophthalmopathy Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Graves' Ophthalmopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Graves' Ophthalmopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Bacterial Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Bacterial Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Bacterial Conjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Bacterial Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Allergic Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Allergic Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Allergic Conjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Posterior Uveitis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Posterior Uveitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Posterior Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Posterior Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Macular Edema Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Macular Edema Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Macular Edema Clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Sector Analysis
Dry Eye Syndrome - Epidemiology Forecast to 2028
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye characterized by dryness, decreased tear production, or increased tear film evaporation. Patients with DES experience symptoms of discomfort, such as visual disturbance and tear film instability (Lemp and Foulks, 2007). Middle-aged and elderly people are most commonly affected because of the high prevalence of contact lens usage, systemic drug effects, autoimmune diseases, and refractive surgeries (Toda et al., 2001; Schaumberg, Sullivan and Dana,...
-
Product Insights
Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The open-angle glaucoma clinical trial market research report provides an overview of open-angle glaucoma clinical trials scenario. The report provides top line data relating to the clinical trials on open-angle glaucoma. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, the report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.